Epigenetically regulated site-specific nucleases
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- THE GENERAL HOSPITAL CORP
- Publication Date
- 2019-09-27
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] priority statement
[0002] This application claims the benefit of U.S. Provisional Application Serial No. 62 / 408,645, filed October 14, 2016. The entire contents of the aforementioned documents are hereby incorporated by reference.
[0003] Federally funded research or development
[0004] This invention was made with US Government support under Grant Nos. DP1 GM105378 and R35GM118158 awarded by the National Institutes of Health. The US Government has certain rights in this invention. technical field
[0005] Described herein are methods for improving genome editing nucleases (such as RNA-guided CRISPR-Cas nucleases or engineered zinc finger nucleases) and customizable DNA-binding domain fusion proteins (such as RNA-guided death cells fused to transcriptional regulatory domains). Cas9, RNA-guided dead Cpf1, or engineered zinc finger arrays) specific methods and compositions for use as research reagents, for gene drives, or as therapeutic agents. Background techniq...